Douglas Holtzman's Insider Trades & SAST Disclosures
Douglas Holtzman's most recent trade in Icosavax Inc was a trade of 16,356 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 3, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Douglas Holtzman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jul 2023 | 16,356 | 28,621 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 03 Jul 2023 | 16,356 | 306,410 | - | 1.0 | 17,010 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 8.74 per share. | 03 Jul 2023 | 14,261 | 292,149 | - | 8.7 | 124,660 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.59 per share. | 03 Jul 2023 | 2,095 | 290,054 | - | 9.6 | 20,083 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 20,443 | 44,977 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 03 Apr 2023 | 20,443 | 310,497 | - | 1.0 | 21,261 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.08 per share. | 03 Apr 2023 | 20,143 | 290,354 | - | 6.1 | 122,439 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.56 per share. | 03 Apr 2023 | 300 | 290,054 | - | 6.6 | 1,968 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 90,000 | 90,000 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.17 per share. | 13 Feb 2023 | 3,349 | 290,054 | - | 10.2 | 34,064 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 10.69 per share. | 13 Feb 2023 | 1,522 | 293,403 | - | 10.7 | 16,274 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 82,580 | 82,580 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Jul 2022 | 20,000 | 22,440 | - | 0 | Common Stock | |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.64 per share. | 29 Jul 2022 | 9,337 | 293,711 | - | 6.6 | 61,973 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.11 per share. | 29 Jul 2022 | 585 | 303,048 | - | 7.1 | 4,158 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.70 per share. | 29 Jul 2022 | 453 | 293,258 | - | 6.7 | 3,037 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 5.77 per share. | 31 May 2022 | 1,667 | 294,925 | - | 5.8 | 9,619 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 81,950 | 81,950 | - | - | Stock Option (Right to Buy) | |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2022 | 19,485 | 303,633 | - | 0 | Common Stock | |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Feb 2022 | 10,000 | 42,440 | - | 0 | Common Stock | |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | 30 Jul 2021 | 206,323 | 0 | - | - | Series A-1 Preferred Stock | ||
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | 30 Jul 2021 | 52,440 | 52,440 | - | 0 | Common Stock | ||
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 15.00 per share. | 30 Jul 2021 | 41,500 | 282,482 | - | 15 | 622,500 | Common Stock |
| Icosavax Inc | Douglas Holtzman | Chief Scientific Officer | 30 Jul 2021 | 11,602 | 0 | - | - | Series B-1 Preferred Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges